Millions of people are turning to ChatGPT for mental health advice—but experts say that could be doing more harm than good. The rise of purpose-built AI for mental health offers a specialized alternative that is safer, more effective, and clinically grounded.
A growing body of evidence suggests that general-purpose AI (GPAI) tools like ChatGPT are being used by consumers for mental health guidance, often without the safeguards or domain expertise needed. In response, a wave of purpose-built AI for mental health applications is emerging—designed from the ground up to provide clinically-informed support, crisis triage, and therapeutic exercises. The shift is driven by mounting concerns about accuracy, privacy, and the potential for harm when people rely on AI that was not designed for sensitive psychological issues.
The trend is not new, but it has accelerated rapidly. Since the launch of ChatGPT in late 2022, users have experimented with asking the chatbot for everything from relationship advice to coping with depression. Surveys indicate that up to 30% of adults have used some form of AI for emotional well-being, and the number is climbing. At the same time, researchers and mental health professionals have flagged cases where GPAI gave inappropriate or even dangerous suggestions—recommending people stop medications, trivializing suicidal thoughts, or providing generic platitudes that failed to recognize severity.
Key details highlight the contrast. Purpose-built mental health AI tools—such as Woebot, Wysa, and Youper—use curated content, evidence-based therapeutic techniques (CBT, DBT), and built-in safety nets that escalate to human professionals when needed. They also comply with health privacy regulations like HIPAA. By contrast, general-purpose AI systems often lack these guardrails. A 2025 study from Stanford University found that only 23% of GPT-4's mental health responses met clinical safety thresholds, compared to 89% for a purpose-built mental health AI. The numbers underscore why the industry is pivoting.
Analysis from AI Insiders and mental health experts points to a larger lesson: one-size-fits-all AI is ill-suited for high-stakes domains. Just as we wouldn't use a general chatbot for medical diagnoses, mental health requires specialized training data, interaction protocols, and accountability. Dr. Sarah Matthews, a clinical psychologist at UCLA, notes that "the empathetic language of a generic AI can be misleading—patients may believe the AI understands them deeply, when in reality it has no grasp of their unique context."
What happens next is already taking shape. Regulatory bodies are beginning to press for clearer labeling: the EU AI Act now classifies mental health AI as high-risk, while the FDA has signaled it will scrutinize any AI that makes therapeutic claims. Meanwhile, startups are racing to refine purpose-built AI for mental health, embedding real-time clinician oversight and cultural sensitivity. For consumers, the message is clear: if you're seeking support, choose a tool designed for the job. General-purpose AI may be convenient, but when it comes to your mental health, purpose-built AI for mental health is the responsible choice.
AI
→ Neutral
Purpose-Built AI For Mental Health Can Suitably Steer People Away From Over-Relying On General-Purpose AI For Their Well-Being Guidance
People use general-purpose AI (GPAI) for mental health advice. There are better ways to do this, by using purpose-built AI. An AI Insider analysis and scoop.
Lance Eliot, Contributor
Forbes
3 min read
6/10
Key Takeaways
- A 2025 Stanford study found that only 23% of GPT-4's mental health responses met clinical safety thresholds, versus 89% for purpose-built AI mental health tools.
- Surveys estimate that 30% of U.S. adults have used general-purpose AI like ChatGPT for emotional or mental health advice, despite lacking clinical oversight.
- Woebot, Wysa, and Youper—purpose-built mental health AI—use evidence-based therapies (CBT, DBT) and include crisis escalation protocols not found in general AI.
- The EU AI Act classifies mental health applications as high-risk, requiring stricter transparency and audit trails for AI systems that provide psychological guidance.
- Venture capital funding for purpose-built mental health AI startups reached $1.2 billion in 2025, up 80% year-over-year, signaling growing investor confidence in specialized solutions.
Frequently Asked Questions
Purpose-built AI for mental health refers to artificial intelligence systems specifically designed to provide psychological support, guidance, or therapy. Unlike general-purpose AI, these tools use curated clinical content, evidence-based techniques like CBT, and have built-in safety features such as crisis escalation to human professionals.
General-purpose AI is trained on broad internet data and lacks mental health expertise, often giving generic or unsafe advice. Purpose-built AI uses specialized training data, adheres to health privacy laws (e.g., HIPAA), and incorporates clinical supervision to ensure responses are safe, empathetic, and evidence-based.
Experts generally advise against it. Studies show that GPT-4's mental health responses fail clinical safety thresholds more than 75% of the time. The AI may provide misleading or harmful suggestions, and it lacks the ability to detect serious issues like suicidal ideation without proper escalation protocols.
These tools offer consistent, accessible support anytime; are grounded in evidence-based practices; include crisis management features; protect user privacy; and can be personalized over time. They don't replace human therapy but serve as a scalable first line of support or complement to professional care.
Yes, risks include over-reliance on AI instead of seeking professional help, privacy breaches if data isn't secured, potential for incorrect advice, and the illusion of empathy. Purpose-built AI reduces many of these risks but cannot fully substitute a trained human therapist.
Look for apps that cite evidence-based approaches (CBT, DBT), have transparent privacy policies, include crisis resources and human escalation options, are developed with clinical oversight, and clearly communicate their limitations. Check for regulatory compliance (e.g., HIPAA) and independent safety reviews.
Topics
Original source
www.forbes.com
Discussion
Join the discussion
Sign in to post a comment or reply.
No comments yet. Be the first to share your thoughts!